DAY ONE BIOPHARMACEUTICALS, INC. logo

DAY ONE BIOPHARMACEUTICALS, INC.

17 Marks
Corp.
First Filed:Nov 14, 2018Latest Filed:Oct 27, 2023Address:1800 Sierra Point Parkway, Suite 200, Brisbane, CA 94005, US

Portfolio Overview

Registered
8(47%)
Pending
1(6%)
Dead
8(47%)

Top Classes

Class 5
Pharmaceuticals
10(59%)
Class 44
Medical, beauty and agricultural services
7(41%)
Class 42
Software, IT Services & Scientific Research
6(35%)

TTAB Proceedings

No litigation activity

Top Firms

FENWICK & WEST LLP(Oct 2023)
16
SHIPMAN & GOODWIN LLP(Aug 2020)
1

Trademark Activity Timeline(2018 – 2026)

Trademark Portfolio

17 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
OJEMDA
OJEMDA
Trademark
Combined
REGISTERED
Owner:
Serial:98244532
Filed:Oct 27, 2023
Classes:5, 42, 44
Registration:7871548
Registered:Jul 22, 2025
Goods & Services
Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of oncological diseases and disorders; targeted pharmaceutical preparations for use in the field of cancer prevention and treatment; pharmaceutical preparations for the delivery of compounds to the body for the treatment and prevention of oncological related diseases and disorders;; Medical information services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding oncological diseases and disorders; Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of oncological diseases and disorders
DAY ONE BIOPHARMACEUTICALS
REGISTERED
Owner:
Serial:98975225
Filed:Sep 21, 2023
Classes:5, 36, 41, +1
Registration:8189842
Registered:Mar 24, 2026
Goods & Services
Educational services, namely, providing online newsletters in the field of prescription drug information via emails, non-downloadable webinars, and online non-downloadable videos in the field of prescription drug information; educational services, namely, providing prescription drug dosage training; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of tumors and cancer; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of pediatric low-grade glioma; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of tumors and cancer; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of pediatric low-grade glioma; providing information regarding tumors and cancer, and pediatric low-grade glioma; Pharmaceutical preparations for human use for treating cancer and oncological diseases; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Healthcare insurance administration services; healthcare insurance administration services, namely, providing benefit verification, authorization and re-authorization support, appeals support, and information regarding benefit updates; providing information about healthcare insurance plans; financial services, namely, assessing sources of and facilitating access by patients and their families to financial support from copay support, patient assistance programs (PAP), patient foundations and organizations; financial services, namely, administration of patient reimbursement programs; BIOPHARMACEUTICALS; Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; research laboratory analysis and research of drugs and pharmaceutical products; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders; research, development, and medical evaluation of pharmaceutical preparations for the prevention and treatment of cancer; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of drugs and pharmaceuticals for the treatment and/or prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
DAY ONE BIOPHARMACEUTICALS
ABANDONED
Owner:
Serial:98191847
Filed:Sep 21, 2023
Classes:44
Goods & Services
Providing pharmaceutical information and support services, namely, providing product information and support services regarding the dosing, administration, and clinical profile of the prescription drugs and treatment of diseases; healthcare services, namely, disease management programs; providing medical information regarding the treatment, and diagnosis of diseases; providing medical information regarding pharmaceutical products for the treatment of diseases; providing medical information and advice for healthcare service providers and patients in connection with pharmaceutical product treatment; healthcare services, namely, providing cancer treatment medical information to physicians, health care professionals, and patients; medical information services, namely, providing medical information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing a website featuring health information in the field of tumors and cancer; providing a website featuring health information in the field of pediatric low-grade glioma; providing medical information regarding the treatment and diagnosis of tumors and cancer; providing medical information regarding the treatment and diagnosis of pediatric low-grade glioma; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with tumors and cancer; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with pediatric low-grade glioma; medical information services regarding tumors and cancer, and pediatric low-grade glioma; providing information regarding the treatment, and diagnosis of diseases; providing medical information relating to prescription drugs; BIOPHARMACEUTICALS
EVERYDAY SUPPORT FROM DAY ONE
PENDING
Owner:
Serial:98093911
Filed:Jul 20, 2023
Classes:36, 41, 44, +1
Goods & Services
Educational services, namely, providing training regarding the treatment, and diagnosis of diseases; educational services, namely, providing prescription drug dosage training; Healthcare insurance administration services; healthcare insurance administration services, namely, providing benefit verification, authorization and re-authorization support, appeals support, and information regarding benefit updates; providing information about healthcare insurance plans; financial services, namely, providing financial patient assistance by providing patients and their families with access to financial support through copay support, patient assistance programs (PAP), and referrals to independent patient foundations and organizations; financial services, namely, financial administration of patient reimbursement programs; healthcare services, namely, wellness and disease management programs; providing medical information regarding the treatment, and diagnosis of diseases; providing medical information regarding pharmaceutical products for the treatment of diseases; providing medical information and advice for healthcare service providers and patients in connection with pharmaceutical product treatment; ; providing information regarding the treatment and diagnosis of cancer; providing medical information relating to prescription drugs; Providing medication adherence support, namely, communicating with patients and caregivers regarding pharmaceutical drug weekly dosing requirements and impediments to taking pharmaceutical drugs as prescribed for medical treatment purposes
OJEMDA
OJEMDA
Trademark
Word
REGISTERED
Owner:
Serial:98030463
Filed:Jun 6, 2023
Classes:5, 42, 44
Registration:7871167
Registered:Jul 22, 2025
Goods & Services
Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of oncological diseases and disorders; targeted pharmaceutical preparations for use in the field of cancer prevention and treatment; pharmaceutical preparations for the delivery of compounds to the body for the treatment and prevention of oncological related diseases and disorders; Medical information services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding oncological diseases and disorders; Research, development, and product evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncology, immunotherapy, chemotherapy, and combination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncology, immunotherapy, chemotherapy and combination therapies; scientific advisory services, namely, providing scientific information, advice, and consultancy in the field of cancer treatment; design, development, research, and testing of new products, namely, drugs and pharmaceuticals for the treatment and/or prevention of oncological diseases and disorders
RETHINK PLGG
RETHINK PLGG
Service Mark
Word
REGISTERED
Owner:
Serial:97724047
Filed:Dec 19, 2022
Classes:35, 41, 44
Registration:7496917
Registered:Sep 3, 2024
Goods & Services
Educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of tumors and cancer; educational services, namely, providing online non-downloadable videos in the field of treatment and diagnosis of pediatric low-grade glioma; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of tumors and cancer; educational services, namely, providing online non-downloadable videos for healthcare service providers, caregivers, and patients in the field of pediatric low-grade glioma; Promoting public awareness of tumors and cancer; promoting public awareness of pediatric low-grade glioma; Providing a website featuring health information in the field of tumors and cancer; providing a website featuring health information in the field of pediatric low-grade glioma; providing medical information regarding the treatment and diagnosis of tumors and cancer; providing medical information regarding the treatment and diagnosis of pediatric low-grade glioma; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with tumors and cancer; providing medical information and health advice for healthcare service providers, caregivers, and patients in connection with pediatric low-grade glioma
ORJEMSA
ORJEMSA
Trademark
Word
ABANDONED
Owner:
Serial:97591746
Filed:Sep 14, 2022
Classes:5, 44
Goods & Services
Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders; targeted pharmaceutical preparations for use in cancer prevention and treatment; pharmaceutical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders; Medical information services; healthcare services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders
ZAYREE
ZAYREE
Trademark
Word
ABANDONED
Owner:
Serial:97591749
Filed:Sep 14, 2022
Classes:5
LUMVYTA
LUMVYTA
Trademark
Combined
ABANDONED
Owner:
Serial:97462842
Filed:Jun 16, 2022
Classes:5
ORPALI
ORPALI
Trademark
Combined
ABANDONED
Owner:
Serial:97462849
Filed:Jun 16, 2022
Classes:44
LUMVYTA
LUMVYTA
Trademark
Word
ABANDONED
Owner:
Serial:97417578
Filed:May 18, 2022
Classes:5
ORPALI
ORPALI
Trademark
Word
ABANDONED
Owner:
Serial:97417564
Filed:May 18, 2022
Classes:5
CANCER DRUG DEVELOPMENT COMES OF AGE
ABANDONED
Owner:
Serial:90127064
Filed:Aug 20, 2020
Classes:42
Goods & Services
"CANCER DRUG DEVELOPMENT"
DAY ONE BIOPHARMACEUTICALS
REGISTERED
Owner:
Serial:88719563
Filed:Dec 9, 2019
Classes:5
Registration:6997035
Registered:Mar 7, 2023
Goods & Services
Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, and neurological disorders; "BIOPHARMACEUTICALS"
DAY ONE BIOPHARMACEUTICALS
REGISTERED
Owner:
Serial:88719553
Filed:Dec 9, 2019
Classes:42
Registration:6196859
Registered:Nov 10, 2020
Goods & Services
"BIOPHARMACEUTICALS"; Research and development in the pharmaceutical and biotechnology fields
DAY ONE
DAY ONE
Service Mark
Word
REGISTERED
Owner:
Serial:88193220
Filed:Nov 14, 2018
Classes:42
Registration:6201030
Registered:Nov 17, 2020
Goods & Services
Research and development in the pharmaceutical and biotechnology fields
DAY ONE
DAY ONE
Trademark
Word
REGISTERED
Owner:
Serial:88193233
Filed:Nov 14, 2018
Classes:5
Registration:7026051
Registered:Apr 11, 2023
Goods & Services
Pharmaceutical preparations for the treatment of cancer, autoimmune disorders, and neurological disorders

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.